Cargando…
Angiographic outcomes in STEMI patients receiving fibrinolysis with guideline directed optimal antithrombotic therapy
STEMI is a major public health problem requiring timely reperfusion. Fibrinolysis remains prevalent reperfusion strategy where timely primary percutaneous coronary intervention (PCI) cannot be performed. Adjunctive antithrombotic agents are of utmost importance for maximizing the benefit of fibrinol...
Autores principales: | Durdana, Shazia, Malik, Mohammad Azharuddin, Hasan, Asif, Rabbani, M.U. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7961247/ https://www.ncbi.nlm.nih.gov/pubmed/33714398 http://dx.doi.org/10.1016/j.ihj.2020.11.011 |
Ejemplares similares
-
Impaired Fibrinolysis in Angiographically Documented Coronary Artery Disease
por: Fernandes, Adriano Basques, et al.
Publicado: (2015) -
Underutilization of Fibrinolysis Despite Timely Arrival in STEMI: A Missed Opportunity!
por: Gnanaraj, Justin Paul, et al.
Publicado: (2023) -
Fibrinolysis is a reasonable alternative for STEMI care during the COVID-19 pandemic
por: Wang, Nan, et al.
Publicado: (2020) -
Impact of COVID-19 on STEMI: Second youth for fibrinolysis or time to centralized approach?
por: Tumminello, Gabriele, et al.
Publicado: (2020) -
Reply: Underutilization of Fibrinolysis Despite Timely Arrival in STEMI: A Missed Opportunity!
por: Bhatia, Kirtipal, et al.
Publicado: (2023)